Career Recognition Award for Professor Paul Glasziou 2024

Career biography

Professor Paul Glasziou commenced at Bond University in 2010 to establish the Centre for Evidence-Based Practice (CREBP). Following immense growth, external funding success and productivity this was transformed into the Institution for Evidenced-Based Healthcare (IEBH) in 2019. Before commencing at Bond, Professor Glasziou was the Director of the Centre for Evidence-Based Medicine in Oxford from 2003 until 2010.

Professor Glasziou is one of the leaders of a small group of international epidemiologists, biostatisticians and clinicians who over the last 40 years have developed the scientific basis of Evidence Based Medicine.

His key interests include identifying and removing the barriers to using high quality research in everyday clinical practice, overdiagnosis and overtreatment, general practice, the uptake of evidence for non-drug interventions, and automation of systematic review processes.

HDR supervision

Bond University Vice Chancellor’s Research Supervision Award in 2017, with 34 research supervisions, including 28 Higher Degree Research and 6 Masters in Primary Health students.

Grant success

During his time at Bond, Professor Paul Glasziou has been awarded 40 HERDC research grants totalling $ 60 million. In recent years Professor Glasziou has been involved in six research teams that have been awarded $18 million in NHMRC funding.

Recent notable grant funding include:

NHMRC Level 3 Investigator grant for Neglected Problems in Health Care.
Gold Coast Hospital Conjoint Evidence Based Practice Professorial Unit Conjoint
MRFF Evidence-based Antimicrobial Stewardship: Sustainable Implementation in Primary Care: EASSI-PC
NHMRC Centre of Research Excellence: Wiser Healthcare – Better value for all Australians

Key achievements

Appointed an Officer of the Order of Australia (AO) in 2021 for distinguished service to medical education and standards, and to evidence-based medical research.
Voted Australia’s leading epidemiologist 2021, a Clarivate Highly Cited Researcher for the past 6 consecutive years and recognised in the top 0.1% of researchers globally.
Bond University Vice Chancellor’s Research Excellence Award for Research Excellence in 2011, 2014 and 2022 for consistent high-quality research outcomes, leadership and innovation.
2015 Elected as a Fellow of the Australian Academy of Health and Medical Sciences
Awarded Charles Bridges -Webb Medal (2011) for international-standard research contributions to academic activities in the primary care environment.
Founding and Chairing the International Collaboration for the Automation of Systematic Reviews.
Membership / Chair of numerous NHMRC committees particularly around Clinical trials and mentorship, MBS item Review, Medical Services review, and on Grant review panels.
Cofounding the International Society of Evidence Based Health Care in 2011.
Editor of BMJ’s Journal of Evidence Based Medicine (1998-2009).

Contribution to the research field/sector

Professor Paul Glasziou has a H-index of 155, including 862 publications and >145,000 citations, which is recognised in the top 0.1% of researchers globally.

Professor Glasziou leads a team that is building capacity in health services research through applied research to improve the efficiency and organisation of health services. This applied research brings economics to the study of healthcare service models, healthcare acquired infection, screening for chronic and infectious diseases, and interventions that change health related behaviour for chronic conditions.

Through his directorship of the IEBH, Professor Glasziou and his team are also world-leaders in systematic review automation. Developing innovative software and methodologies, whilst also training academics and clinicians. The impact of these innovations is widespread, one recent example is the influence on health policy regarding permanent implementation of telehealth, which now greatly increases healthcare access for all Australians.

Leadership and mentoring

Professor Glasziou is an internationally recognised and highly accomplished expert in the field of public health. Beyond his roles at Bond University, he has significant national and international leadership including the NHMRC and EQUATOR, in addition to work with the WHO. These committees and international collaborators, have been able to inform and influence health policy, contributing to improved global health outcomes and reducing unnecessary healthcare expenditure.

The Institute is one of five global EQUATOR centres committed to improving research quality and reproducibility to avoid research waste. The team has estimated that avoidable design flaws, non-publication, and inadequate reporting, renders over 85% of medical research a wasted effort. This equates to over $100 billion dollars' worth of avoidable research waste globally every year.

The Institute led the Department of Health contract for evidence syntheses of all existing trial evidence around the effectiveness, safety, and economics of the provision of primary and allied healthcare via telehealth. The transformative impact of this research informed the Australian Government to implement telehealth permanently from 1 January 2022.

Other recent senior leadership roles include chair of the NHMRC Research Quality Steering Committee, chair of the RACGP Handbook of Non-Drug Interventions (HANDI) Committee, co-director of the Australasian EQUATOR Centre, and a member of the MBS (Medicare Benefits Schedule) Review Taskforce (2015-2020).